Search
170 studies match these filters. Showing 151–170 of 170 studies
| Registration number | Study | Status | Phase | Enrolment | Sites / countries | Start year | Last updated | Actions |
|---|---|---|---|---|---|---|---|---|
| NCT03072927 | MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study This prospective longitudinal study will compare incidence rates of Medicare beneficiary surgical and minimally invasive intervention post index procedure, as well as harms associated with the MILD procedure, at 24 months post-treatment with MILD, tested against a control group of similar patients t… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 2,450 sites in total · contact listed | Recruiting | 8,000target | 2,450 / 1 | 2017 | Nov 19, 2026 | ||
| NCT06779630 | Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions The purpose of the study is to assess the safety and efficacy of the Orsiro® Mission 48- mm Sirolimus-Eluting Coronary Stent System in the treatment of subjects with atherosclerotic lesion(s) \>36 mm and ≤ 44 mm in length (by visual estimate) in the native coronary arteries with a reference vessel d… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 23 sites in total | Recruiting | Not applicable | 150target | 23 / 6 | 2025 | Nov 5, 2026 | |
| NCT07090161 | Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 28 sites in total | Recruiting | Phase 2 | 240target | 28 / 1 | 2025 | Feb 27, 2026 | |
| NCT06060041 | IC-8 Apthera IOL New Enrollment Post Approval Study The purpose of this study is to verify the post-market safety of the IC-8 Apthera IOL after the treatment of posterior capsular opacification (PCO), an expected complication related to IC-8 Apthera IOL implantation. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 14 sites in total | Recruiting | 435target | 14 / 1 | 2023 | Jan 12, 2026 | ||
| NCT05061004 | Cephea Early Feasibility Study The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 22 sites in total · contact listed | Recruiting | Not applicable | 90target | 22 / 2 | 2022 | Sep 11, 2026 | |
| NCT06545955 | A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer The pivotal phase 3 trial (rAd-IFN-CS 003) evaluating the efficacy of nadofaragene firadenovec showed that 55 (53.4%) of 103 subjects with CIS ± high-grade Ta/T1 achieved a complete response (CR) at 3 months. In this trial, the safety and efficacy of intravesical instillation of nadofaragene firaden… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 81 sites in total | Recruiting | Phase 3 | 250target | 81 / 8 | 2024 | Nov 12, 2026 | |
| NCT04553770 | Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer This phase II trial investigates how well trastuzumab deruxtecan works alone or in combination with anastrozole in treating patients with HER2 low, hormone receptor positive breast cancer. Trastuzumab deruxtecan is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug called derux… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 9 sites in total · contact listed | Recruiting | Phase 2 | 88target | 9 / 1 | 2020 | Nov 10, 2025 | |
| NCT05929768 | Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells fr… ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 963 sites in total · contact listed | Recruiting | Phase 3 | 2,400target | 963 / 3 | 2023 | Nov 5, 2025 | |
| NCT05304585 | Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy using treatment with 24 weeks of vincristine and dactinomycin (V… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 181 sites in total · contact listed | Recruiting | Phase 3 | 205target | 181 / 4 | 2022 | Aug 25, 2026 | |
| NCT04889872 | PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve systems in subjects with moderate, calcific aortic stenosis. Following completion of enrollment, subjects will be eligible for enrollment in… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 80 sites in total | Recruiting | Not applicable | 2,250target | 80 / 6 | 2021 | Dec 17, 2025 | |
| NCT06556654 | Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE) The GORE Tissue Reinforcement for Breast Reconstruction (TRBR) research study will look at breast reconstruction during mastectomy procedures. There will be two arms in this study, a Treatment Arm, where data will be collected for a new medical device called the Tissue Reinforcement for Breast Recon… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 20 sites in total · contact listed | Recruiting | Not applicable | 180target | 20 / 1 | 2025 | Oct 23, 2025 | |
| NCT07209397 | Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women The goal of this clinical trial is to learn if a vaginal radiofrequency (RF) device called MORPHEUSV works to treat overactive bladder (OAB) in women. Researchers also want to learn how safe the device is for this indication. This study will include women ages 22 to 80 who have had OAB symptoms for… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 9 sites in total · contact listed | Recruiting | Not applicable | 202target | 9 / 1 | 2025 | Jan 30, 2026 | |
| NCT06122077 | Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening The PROACT LUNG study is a prospective multi-center observational study to validate a blood-based test for the early detection of lung cancer by collecting blood samples from high-risk participants who will undergo a routine, standard-of-care screening Low-Dose Computed Tomography (LDCT). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 36 sites in total · contact listed | Recruiting | 20,000target | 36 / 1 | 2023 | Aug 5, 2025 | ||
| NCT06942949 | Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial The purpose of this study is to evaluate the safety and performance of the ELS to treat urinary stones. The ELS is intended to break urinary stones into small fragments that can pass during or after the procedure with less or no discomfort. Eligible patients are male or females, age 21 or older, wit… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 20 sites in total · contact listed | Recruiting | Not applicable | 101target | 20 / 1 | 2025 | Jun 16, 2026 | |
| NCT05862272 | A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis The purpose of this clinical trial to characterize changes in bone mineral density during continuous treatment with relugolix combination tablet for up to 48 months (4 years) and 1 year of post-treatment follow-up in premenopausal women with heavy menstrual bleeding associated with uterine leiomyoma… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 120 sites in total | Recruiting | Phase 3 | 1,000target | 120 / 1 | 2023 | Aug 6, 2025 | |
| NCT04634240 | Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise re… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 72 sites in total · contact listed | Recruiting | Not applicable | 4,000target | 72 / 2 | 2020 | Jul 24, 2025 | |
| NCT05561114 | Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus To evaluate the safety and efficacy of the ProTractX3™ DCB for the treatment of benign esophageal strictures. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 34 sites in total · contact listed | Recruiting | Phase 3 | 198target | 34 / 1 | 2023 | Jun 25, 2025 | |
| NCT05561127 | Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel To determine the safety and efficacy of GIE Medical's ProTractX3™ TTS DCB for the treatment of recurrent benign bowel strictures. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 33 sites in total · contact listed | Recruiting | Phase 3 | 171target | 33 / 1 | 2023 | Jun 25, 2025 | |
| NCT05336240 | PCOM2 - The Physician Communication Intervention, Version 2.0 Poor quality of primary care providers' vaccine recommendations lead to low adolescent human papillomavirus vaccination rates and hundreds of thousands of adolescents unnecessarily at risk for HPV-associated cancers and diseases. Though a previous provider communication intervention, called PCOM, wa… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 2 sites in total · contact listed | Recruiting | Not applicable | 120target | 2 / 1 | 2023 | Aug 26, 2024 | |
| NCT01574053 | Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 183 sites in total · contact listed | RecruitingNot verified since Feb 1, 2024 | 35,000target | 183 / 20 | 2012 | Feb 28, 2024 |